Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001586226-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
12,265
Total Value
$207,159.52
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 3,955 | $8.33 | $32,945.15 | 35,694 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 10, 2026 | Sale | 4,355 | $40.00 | $174,214.37 | 31,339 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 10, 2026 | Exercise/Conversion | 3,955 | $0.00 | $0.00 | 118,696 | Direct | โ | View Details |